Document Detail


Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis.
MedLine Citation:
PMID:  23417685     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVES: The development of resistance to multiple antimicrobial agents has limited treatment options for gonorrhoea. The potential emergence of cephalosporin resistance in Neisseria gonorrhoeae and cephalosporin allergy in some patients make it necessary to evaluate the effectiveness of other available antimicrobial agents. Gentamicin is widely available in the USA and is used for gonorrhoea treatment in several countries. We conducted a systematic review of the medical literature to assess the effectiveness of gentamicin for treatment of uncomplicated urogenital gonococcal infections.
METHODS: Two reviewers assessed relevant articles and independently selected studies that met prespecified selection criteria (including systematic enrolment and assignment to treatment and culture-confirmed diagnosis and outcome). Summary measures for selected studies were pooled using inverse variance-weighted averages with fixed effects. Heterogeneity was assessed using I(2), which estimates proportion (0-100%) of variability attributable to heterogeneity between studies. Pooled percentage with negative follow-up culture was compared with Centers for Disease Control and Prevention (CDC) criteria for selection of recommended therapy (lower 95% CI of efficacy ≥95%).
RESULTS: Twenty-nine potentially relevant studies were identified; three met inclusion criteria. Two studies used 240 mg intramuscular gentamicin and one used 280 mg. Percentages with negative culture after single-dose treatment were 90.7% (n=86), 91.4% (n=220) and 95.0% (n=40). Pooled percentage with negative culture after single-dose treatment was 91.5% (95% CI 88.1% to 94.0%, I(2)=0%).
CONCLUSIONS: Gentamicin does not meet current CDC criteria for recommended treatment of gonorrhoea. However, if cephalosporin resistance emerges, gentamicin may be a useful alternative agent. Evaluation of additional regimens, including combination therapy, is warranted.
Authors:
Deborah Dowell; Robert D Kirkcaldy
Related Documents :
23291425 - Importance of proper patient selection and endpoint selection in evaluation of new ther...
23241565 - What place for {blacktriangledown}cannabis extract in ms?
24596645 - Patients' preferences for selection of endpoints in cardiovascular clinical trials.
24199775 - A systematic review of the evidence for topical use of ginger.
22872105 - Population impact of depression on functional disability in elderly: results from "são...
10541775 - Assessment of analgesia in human chronic pain. randomized double-blind crossover study ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Postgraduate medical journal     Volume:  89     ISSN:  1469-0756     ISO Abbreviation:  Postgrad Med J     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0234135     Medline TA:  Postgrad Med J     Country:  England    
Other Details:
Languages:  eng     Pagination:  142-7     Citation Subset:  IM    
Affiliation:
New York City Department of Health and Mental Hygiene, Office of the Commissioner, 42-09 28th Street, 8-62, Queens, New York 11101, USA. ddowell1@health.nyc.gov.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is Permanent Parasitism Reversible? - Critical Evidence from Early Evolution of House Dust Mites.
Next Document:  Republished: Drug-induced valvular heart disease.